Drug Price Controls in Medicare Part D: Not a Remedy for More Than 5 Million Medicare Beneficiaries Read more about Drug Price Controls in Medicare Part D: Not a Remedy for More Than 5 Million Medicare Beneficiaries
NPC Comments on HHS Notice of Benefit and Payment Parameters for 2023 Read more about NPC Comments on HHS Notice of Benefit and Payment Parameters for 2023
How the Myth of Average Persists in Health Benefits Read more about How the Myth of Average Persists in Health Benefits
Achieving “Fair Access” Requires Better Benefit Design Read more about Achieving “Fair Access” Requires Better Benefit Design
The Patient’s Medication Access Journey: A Conceptual Framework Focused Beyond Adherence Read more about The Patient’s Medication Access Journey: A Conceptual Framework Focused Beyond Adherence
Making Our Health Care System More Supportive and Inclusive for Caregivers Read more about Making Our Health Care System More Supportive and Inclusive for Caregivers
AMCP Partnership Forum: Exploring Paths to Equitable Benefit Design Read more about AMCP Partnership Forum: Exploring Paths to Equitable Benefit Design
Affordability Is About More Than Drug Prices Read more about Affordability Is About More Than Drug Prices
Drug Innovations Are Delivering for Patients. We Need Innovation in How They’re Paid For. Read more about Drug Innovations Are Delivering for Patients. We Need Innovation in How They’re Paid For.
Rethinking Benefit Design: Eliminating Inefficient Hurdles Read more about Rethinking Benefit Design: Eliminating Inefficient Hurdles